Misonix, Inc. (NASDAQ:MSON) Surges Ahead With Its BoneScalpel Support For Ugandan Spine Surgery Mission
Dallas, Texas, 09/24/2014 (ustrademedia) – Misonix, Inc. (NASDAQ:MSON) in a Tuesday news update announced that it has once again affirmed its support for the Uganda Spine Surgery Mission, led by spine surgeon Dr. Isador Liberman. The company is a leading surgical device maker and has many of the world’s most popular spine surgery, skull surgery as well as cosmetic surgery devices on its product list.
Provides its BoneScalpel for Ugandan Spine surgery Mission
Misonix, Inc. (NASDAQ:MSON) as a follow up to its speciality medical products production will provide its latest Ultrasonic BoneScalpel, an advanced technology/device to the Ugandan Mission via Dr.Isador, who comes from the Texas Back Institute in Texas, Plano.
The Mission was the brain child of Dr. Liberman and Ugandan-origin Dr.Mark Kayanja to offer advanced spine care to patients in remote parts of Uganda. Over the years, the surgeries which are held once in a year, has seen the number of patients grow enormously. This has led to the Mission offering three teams to deliver the services, this year.
For Misonix, Inc. (NASDAQ:MSON) this is the third year in a row, when it is donating its device. The ultrasound BoneScalpel is appreciated for its complex bone removal precision, as well as, the lessened trauma it causes on the soft tissues and also the low-levels of bleeding in the patient.
Dr. Shane Burch who works at the UCSF Medical Center in San Francisco, CA has this to say about the bonescalpel by Misonix, “In my view BoneScalpel’s main advantage is that it is efficient and I value the amount of bone graft one is able to harvest from the spine.”
Michael A. McManus, Jr., President and Chief Executive Officer of Misonix, Inc. (NASDAQ:MSON) conclude, “BoneScalpel as participants in this year’s mission is testimony to the clinical importance of our unique technology and its rapidly increasing adoption rate around the world.”